BE467018A - - Google Patents
Info
- Publication number
- BE467018A BE467018A BE467018DA BE467018A BE 467018 A BE467018 A BE 467018A BE 467018D A BE467018D A BE 467018DA BE 467018 A BE467018 A BE 467018A
- Authority
- BE
- Belgium
- Prior art keywords
- proteins
- solution
- protein
- temperature
- precipitating agent
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 claims description 137
- 108090000623 proteins and genes Proteins 0.000 claims description 137
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 86
- 239000000243 solution Substances 0.000 claims description 64
- 108010088751 Albumins Proteins 0.000 claims description 56
- 102000009027 Albumins Human genes 0.000 claims description 56
- 238000000034 method Methods 0.000 claims description 47
- 239000003795 chemical substances by application Substances 0.000 claims description 43
- 230000001376 precipitating effect Effects 0.000 claims description 41
- 210000002381 plasma Anatomy 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 21
- 239000012528 membrane Substances 0.000 claims description 19
- 239000002244 precipitate Substances 0.000 claims description 19
- 238000000926 separation method Methods 0.000 claims description 18
- 238000001556 precipitation Methods 0.000 claims description 16
- 239000012460 protein solution Substances 0.000 claims description 13
- 229940012952 fibrinogen Drugs 0.000 claims description 12
- 238000005194 fractionation Methods 0.000 claims description 12
- 108010049003 Fibrinogen Proteins 0.000 claims description 11
- 102000008946 Fibrinogen Human genes 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 11
- 230000008014 freezing Effects 0.000 claims description 9
- 238000007710 freezing Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 229920000298 Cellophane Polymers 0.000 claims description 7
- 238000009792 diffusion process Methods 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- -1 hydrogen ions Chemical class 0.000 claims description 6
- 239000008247 solid mixture Substances 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 150000002500 ions Chemical class 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000007853 buffer solution Substances 0.000 claims description 4
- 230000006920 protein precipitation Effects 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 230000015271 coagulation Effects 0.000 claims description 3
- 238000005345 coagulation Methods 0.000 claims description 3
- 239000003792 electrolyte Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims 2
- 101100113998 Mus musculus Cnbd2 gene Proteins 0.000 claims 1
- 102000007562 Serum Albumin Human genes 0.000 claims 1
- 108010071390 Serum Albumin Proteins 0.000 claims 1
- 239000003146 anticoagulant agent Substances 0.000 claims 1
- 229940127090 anticoagulant agent Drugs 0.000 claims 1
- 210000000601 blood cell Anatomy 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 239000000376 reactant Substances 0.000 claims 1
- 102000006395 Globulins Human genes 0.000 description 22
- 108010044091 Globulins Proteins 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 9
- 239000013078 crystal Substances 0.000 description 7
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 7
- 230000037230 mobility Effects 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 230000006866 deterioration Effects 0.000 description 5
- 102000002572 Alpha-Globulins Human genes 0.000 description 4
- 108010068307 Alpha-Globulins Proteins 0.000 description 4
- 102000006734 Beta-Globulins Human genes 0.000 description 4
- 108010087504 Beta-Globulins Proteins 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 108010094028 Prothrombin Proteins 0.000 description 3
- 102100027378 Prothrombin Human genes 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 108010074605 gamma-Globulins Proteins 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 229940039716 prothrombin Drugs 0.000 description 3
- 238000005199 ultracentrifugation Methods 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- 102000008100 Human Serum Albumin Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 102000005686 Serum Globulins Human genes 0.000 description 2
- 108010045362 Serum Globulins Proteins 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000012716 precipitator Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 108091005979 iodinated proteins Proteins 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 229940040511 liver extract Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/06—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from blood
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE467018A true BE467018A (cs) |
Family
ID=118162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE467018D BE467018A (cs) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE467018A (cs) |
-
0
- BE BE467018D patent/BE467018A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2390074A (en) | Protein product and process | |
| Kuronen et al. | A new purification procedure and molecular properties of Pseudomonas cytochrome oxidase | |
| Puchtler et al. | Methacarn (methanol-Carnoy) fixation: practical and theoretical considerations | |
| EP0085005B1 (fr) | Procédé de séparation d'immunoglobulines à partir du colostrum | |
| US2469193A (en) | Protein fractionation | |
| Zetina et al. | Kinetics of renaturation and self-assembly of intermediates on the pathway of folding of the β2-subunit of Escherichia coli tryptophan-synthetase | |
| PT789750E (pt) | Produto biologico para a estabilizacao fisico-quimica dos vinhos | |
| Tjalsma et al. | Hydrophobic deep eutectic solvents as novel, sustainable aids for intracellular protein release from Saccharomyces cerevisiae | |
| Smith-Johannsen et al. | Reversible dissociation of ferritin and its subunits in vitro | |
| BE467018A (cs) | ||
| WO2019034955A1 (en) | PROCESS FOR PURIFYING PHYCOCYANINE | |
| EP0125981B1 (fr) | Procédé de purification de la dextrane-saccharase | |
| Jernej et al. | A simple and reliable method for monitoring platelet serotonin levels in rats | |
| CH652932A5 (fr) | Procede pour la preparation d'un concentrat purifie de facteur antihemophile. | |
| SU910135A3 (ru) | Способ отделени гемо-железа от глобина | |
| Hotani | Interconversion between flagella and P-filament in vitro | |
| FR2569722A1 (fr) | Procede pour l'obtention de lysozyme par microfiltration a partir d'une matiere a base de blanc d'oeuf | |
| Katakai et al. | Conformational studies of the synthetic hydrophobic sequences in signal peptides of secretory proteins | |
| CN108727487B (zh) | 一种水蛭素的液膜萃取方法 | |
| CA3121693A1 (fr) | Amphipols | |
| EP0077796A1 (fr) | Medicament nouveau constitue par un complexe aprotinine-plasmine et procede de preparation de ce nouveau complexe | |
| EP0383645B1 (fr) | Procédé de fabrication du facteur antihémophilique (FVIIIc) ayant une très haute pureté. | |
| EP1223177B1 (fr) | Procédé de production d'une fraction purifiée de lipoprotéines de faible densité de jaune d'oeuf et milieu de conservation incorporant de telles lipoprotéines | |
| CN1020734C (zh) | 提取超氧化物歧化酶复合物的方法 | |
| JPS6042800B2 (ja) | 強心剤 |